1,Data from studies on long-acting injectable HIV medications for treatment and prevention will be available. The hope is that HIV-positive folks will be required to have only one injection session per month. Even better news: Less frequent injections may be effective in preventing HIV.Such new injection will bring more compliance or person will take it easily without failure as complete adhreance leading to no break in therapy or drug resistance.secondly it will be less toxic to patients health so now HIV TREATMENT WILL BE STARTED soon as it is detected rather than wait till cd4 downs to 500 or 350 or 200 where more infections and tumors come as a result of side effects.As started early so person will be less contagious for spreading disease to others in contact or may think for hiv negative baby as viral load will be minimum so transmission will be less or person will not suffer much as less oppurtunistic lesions will occur SO BOTH QUALITY AND QUANTITY OF LIFE WILL BE GOOD.
Cost of therapy will be 
2.POST EXPOSURE PROPHYLAXIS TO HIV NEGATIVE PERSONS COMING IN CONTACT WITH HIV PERSONS BY BLOOD OR UNSAFE SEX OR MOTHER TO CHILD IF GIVEN POST EXPOSURE PROPHYLAXSIS WITHIN 72 HRS EITHER 02 OR 03 MEDICINES AS ASSESSING AFTER VIRULANCE OF CONTACT IS A WELL ESTABLISHED PROCEDURE AND IS VERY HELP FUL NOW SOME BEST COMBINATION SINGLE PILL IS AVIALBALE IN MARKET.
3.Pre-exposure prophylaxis (PrEP) will expand in whole world as it is a known fact that it prevents HIV TRANSMISSIONS IN GAY VERY MUCH IF TAKEN BY CO INMATES WHO ARE NEGATIVE EVEN IN HETEROSEXUAL SEX IT IS VERY EFFECTIVE SO HIV NEGATIVE PARTENERS OF POSITIVE HOMO OR HETROSEXUAL SHOULD TAKE IT AND THIS THERAPY SHOULD BE TAKEN DAILY NOT INTERMITTENTLY AND WITH IT CONDOM SHOULD BE USED AS CONDOM PREVENTS OTHER SEXUAL TRANSMITTED DISEASES TOO BESIDE HIV/AIDS.
4.More one-pill, once-a-day combination regimens will receive FDA approval as more pharmaceutical companies collaborate.RECENTRY TRIMEQ OR 572 trii added beside already prevalent viraday /atripla / complera /trustiva /stribild etc
5.Patients running out of treatment options for resistant HIV will have access to two attachment inhibitors at the same time. Researchers hope these two agents will treat multi-resistant HIV since they provide a different mode of action.
6HIV cure research will overcome recent setbacks as more effective HIV reservoir-purging compounds and immune-based approaches are studied and more stress by idenifying genome realted protein to manufacture vaccine is on the way 
6.Gene threapy is anew approach reasearch are going on to detect nano particles which can modify either genome structure of offending virus to make it less virulant or make cellular genome so hard and tough as virus cannot damage it.